This Article Full Text Full Text (PDF) All Versions of this Article: 45/6/1119    most recent 01.HYP.0000164577.81087.70v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Peralta, C. A. Articles by Shlipak, M. G. Search for Related Content PubMed PubMed Citation Articles by Peralta, C. A. Articles by Shlipak, M. G. Pubmed/NCBI databases Medline Plus Health Information High Blood Pressure Related Collections Other hypertension

(Hypertension. 2005;45:1119.)
© 2005 American Heart Association, Inc.

Original Articles

Control of Hypertension in Adults With Chronic Kidney Disease in the United States

Carmen A. Peralta; Leroi S. Hicks; Glenn M. Chertow; John Z. Ayanian; Eric Vittinghoff; Feng Lin; Michael G. Shlipak

From the General Internal Medicine Section (C.A.P., M.G.S.), San Francisco Veterans Affairs Medical Center, California; Division of Nephrology (C.A.P., G.M.C., M.G.S.), Department of Medicine, University of California San Francisco; Department of Epidemiology and Biostatistics (G.M.C., E.V., F.L., M.G.S.), University of California San Francisco; Division of General Internal Medicine (L.S.H., J.Z.A.), Brigham and Women’s Hospital, Boston, Mass; and Department of Health Care Policy (L.S.H., J.Z.A.), Harvard Medical School, Boston, Mass.

Correspondence to Carmen A. Peralta, MD, General Internal Medicine, Department of Veterans Affairs, Box 111A1, 4150 Clement St, San Francisco, CA 94121. E-mail Carmen.Peralta{at}med.va.gov

Although improved control of hypertension is known to attenuate progression of chronic kidney disease (CKD), little is known about the adequacy of hypertension treatment in adults with CKD in the United States. Using data from the Fourth National Health and Nutrition Survey, we assessed adherence to national hypertension guideline targets for patients with CKD (blood pressure <130/80 mm Hg), we assessed control of systolic (<130 mm Hg) and diastolic (<80 mm Hg) blood pressure, and we evaluated determinants of adequate blood pressure control. Presence of CKD was defined as glomerular filtration rate <60 mL/min per 1.73 m² or presence of albuminuria (albumin:creatinine ratio >30 µg/mg). Multivariable logistic regression with appropriate weights was used to determine predictors of inadequate hypertension control and related outcomes. Among 3213 participants with CKD, 37% had blood pressure <130/80 mm Hg (95% confidence interval [CI], 34.5% to 41.8%). Of those with inadequate blood pressure control, 59% (95% CI, 54% to 64%) had systolic >130 mm Hg, with diastolic 80 mm Hg, whereas only 7% (95% CI, 3.9 to 9.8%) had a diastolic pressure >80 mm Hg, with systolic blood pressure 130 mm Hg. Non-Hispanic black race (odds ratio [OR], 2.4; 95% CI, 1.5 to 3.9), age >75 years (OR, 4.7; 95% CI, 2.7 to 8.2), and albuminuria (OR, 2.4; 95% CI, 1.4 to 4.1) were independently associated with inadequate blood pressure control. We conclude that control of hypertension is poor in participants with CKD and that lack of control is primarily attributable to systolic hypertension. Future guidelines and antihypertensive therapies for patients with CKD should target isolated systolic hypertension.

Key Words: kidney • race

This article has been cited by other articles:

				D. A. Calhoun, D. Jones, S. Textor, D. C. Goff, T. P. Murphy, R. D. Toto, A. White, W. C. Cushman, W. White, D. Sica, et al. Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Circulation, June 24, 2008; 117(25): e510 - e526. [Abstract] [Full Text] [PDF]

				D. A. Calhoun, D. Jones, S. Textor, D. C. Goff, T. P. Murphy, R. D. Toto, A. White, W. C. Cushman, W. White, D. Sica, et al. Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Hypertension, June 1, 2008; 51(6): 1403 - 1419. [Abstract] [Full Text] [PDF]

				R. Minutolo, S. Borrelli, R. Scigliano, V. Bellizzi, P. Chiodini, B. Cianciaruso, F. Nappi, P. Zamboli, G. Conte, and L. De Nicola Prevalence and clinical correlates of white coat hypertension in chronic kidney disease Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2217 - 2223. [Abstract] [Full Text] [PDF]

				N. I. Parikh, S.-J. Hwang, M. G. Larson, J. B. Meigs, D. Levy, and C. S. Fox Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Intern Med, September 25, 2006; 166(17): 1884 - 1891. [Abstract] [Full Text] [PDF]

				W. McClellan, D. G. Warnock, L. McClure, R. C. Campbell, B. B. Newsome, V. Howard, M. Cushman, and G. Howard Racial Differences in the Prevalence of Chronic Kidney Disease among Participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1710 - 1715. [Abstract] [Full Text] [PDF]